Search for European Projects

16 European Projects Found

Searched on 125080 European Projects

 FINISHED 
IN-SENS is an interdisciplinary, cutting-edge European industry-academia collaborative effort for a novel training of scientists in molecular psychiatry with the prospect of discovering the biology of schizophrenia and actively promote drug discovery. Mental illnesses are a major burden to patients, relatives, and public health worldwide. IN-SENS therefore aims to profoundly change the academic-in ...
Read Project

 16

 FINISHED 

Innovative risk-based tools for ship safety inspection (SAFEPEC)

Start date: Oct 1, 2014, End date: Sep 30, 2017,

"Ships are subject to inspections from different stakeholders, such as port states, classification societies, ship owners, managers and operators, among others. Each one has its own inspection method depending upon its role in the vessel operation. Consequently, all inspections monitor the ship condition and report respective data. However no means exist today to inter-relate the data which are sy ...
Read Project

 9

 FINISHED 
"GLADIATOR (Graphene Layers: Production, Characterization and Integration) will enable the scalable production of cheaper, higher quality and larger area graphene sheets. The project will achieve this by optimizing the performance of CVD graphene (using doping), by increasing the throughput and size of CVD batch reactors, and by improving the process by which graphene is transferred for the CVD ca ...
Read Project

 16

 FINISHED 

Code for European Severe Accident Management (CESAM)

Start date: Apr 1, 2013, End date: Mar 31, 2017,

The Fukushima accidents highlighted that both the in-depth understanding of such sequences and the development or improvement of adequate severe accident management measures is essential in order to further increase the safety of the nuclear power plants operated in Europe. CESAM (Code for European Severe Accident Management) is a R&D project that aims in particular at the improvement of the Europ ...
Read Project

 21

 FINISHED 
Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core symptoms of autism spectrum disorder (ASD). Major obstructions to this include a lack of aetiologically-driven or pathophysiologically-accurate animal models; an absence of tests that indicate efficacy; and reliance of clinical trials on DSM/ICD10 categories wh ...
Read Project

 29

 FINISHED 

Computing Veracity Across Media, Languages, and Social Networks (PHEME)

Start date: Jan 1, 2014, End date: Dec 31, 2016,

Social media poses three major computational challenges, dubbed by Gartner the 3Vs of big data: volume, velocity, and variety. Content analytics methods have faced additional difficulties, arising from the short, noisy, and strongly contextualised nature of social media. In order to address the 3Vs of social media, new language technologies have emerged, e.g. using locality sensitive hashing to de ...
Read Project

 9

 FINISHED 
The eTOX consortium proposes to develop innovative methodological strategies and novel software tools to better predict the toxicological profiles of new molecular entities in early stages of the drug development pipeline. This will be achieved by coordinating the efforts of specialists from academia and SMEs in the wide scope of disciplines that are required to move towards a more reliable modell ...
Read Project

 30

 FINISHED 

Learning from Innovation in Public Sector Environements (LIPSE)

Start date: Feb 1, 2013, End date: Jul 31, 2016,

"The LIPSE project (Learning from Innovation in Public Sector Environments) identifies drivers and barriers to successful social innovation in the public sector. Through studying social innovation and co-creation practices and processes in 11 European countries and 7 policy sectors, LIPSE will create and disseminate essential knowledge about public innovation. The LIPSE consortium consists of lead ...
Read Project

 12

 FINISHED 

Electronic Health Record systems for Clinical Research (EHR4CR)

Start date: Mar 1, 2011, End date: Feb 29, 2016,

Current medical needs, the growth of targeted therapies and personalized medicines, and escalating R&D costs result in formidable cost pressures on healthcare systems and the pharmaceutical industry. Clinical research is also growing in complexity, labour intensity and cost. There is a growing realization that the development and integration of Electronic Health Record systems (EHRs) for medical ...
Read Project

 37

 FINISHED 
An absolute or relative loss of beta-cell mass and function underlie the development of type I and type 2 diabetes.Preventing beta-cell demise or restoring their number and function is a major therapeutic goal. However,development of novel diagnostic and prognostic tools, and of novel therapeutic modalities, is hampered by the limited knowledge of the molecular pathways that control beta-cell demi ...
Read Project

 23

 FINISHED 
Recent pharmacovigilance (PV) issues have led to questions regarding the ability of the current PV system to meet the global needs. Controversies around the assessment of spontaneous reports and conflicting results from pharmacoepidemiology studies may lead to delay in, or inappropriate, regulatory decisions. The PROTECT consortium, consisting of 20 core partners lead by the European Medicines Age ...
Read Project

 36

 FINISHED 

ROll To Roll production of Organic Tandem cells (ROTROT)

Start date: Sep 1, 2011, End date: Aug 31, 2014,

ROTROT (ROll to Roll production of Organic Tandem cells) project addresses "Flexible, Organic and Large Area Electronic and photonics". OLAE potentially offers a giant step for consumer electronics and will continue to address mass market applications. In this OLAE field, Organic Photovoltaic (OPV) has to compete with Si and Thin Film PV. OPV has followed this tremendous growth and makes important ...
Read Project

 8

 FINISHED 
Inhibition of angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a well established therapeutic strategy against cancer. Inhibitors of angiogenesis have been developed to block tumour growth and metastasis, and a number of these inhibitors are now clinically approved. However, contrary to initial expectations, angiogenesis inhibitors can cause a range of toxicities ...
Read Project

 11

 FINISHED 

Breakthrough in European Ship and Shipbuilding Technologies (BESST)

Start date: Sep 1, 2009, End date: Feb 28, 2013,

"Initiated by EUROYARDS, BESST aims to achieve a breakthrough in competitiveness, environmentally friendliness and safety of EU built ships. Focusing on passenger ships, ferries and mega-yachts, the results will to a large extend be applicable also to other ships. A holistic life cycle performance assessment on ship level will guide the technical developments on system level, clustered in System G ...
Read Project

 70

 FINISHED 
Astroparticle Physics has become a mature and well accepted science discipline. Demonstrated by many world class projects currently developed and run by European Astroparticle physicists, Europe as a whole is the main promoter and leading the field. As a merit of ASPERA (AStroparticle Physics European Research Area network, http://www.aspera-eu.org ), the ERA-NET in Astroparticle Physics funded in ...
Read Project

 22

 FINISHED 
"At present more than 5 million people in the EU suffer from dementia and other neurodegenerative diseases and that number will grow as the average age of the population continues to increase. The efficacy of current medicines is limited and new therapeutic targets are sorely needed. Several independent lines of evidence have established an important role of prolyl oligopeptidase (PREP) in brain f ...
Read Project

 12